Related Articles
Indirect comparison of the efficacy and safety of gefitinib and cetuximab‑based therapy in patients with advanced non‑small‑cell lung cancer
EGFR methylation and outcome of patients with advanced colorectal cancer treated with cetuximab
p16 promoter hypermethylation is associated with increased risk of nasopharyngeal carcinoma
Lenvatinib‑based treatment regimens in conversion therapy of unresectable hepatocellular carcinoma: A systematic review and meta‑analysis
Precision drugs for recurrent or metastatic nasopharyngeal carcinoma (Review)